• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢组学在抗癌药物研发中的应用:系统评价。

Metabolite Profiling in Anticancer Drug Development: A Systematic Review.

机构信息

Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.

Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.

出版信息

Drug Des Devel Ther. 2020 Apr 9;14:1401-1444. doi: 10.2147/DDDT.S221518. eCollection 2020.

DOI:10.2147/DDDT.S221518
PMID:32308372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7154001/
Abstract

Drug metabolism is one of the most important pharmacokinetic processes and plays an important role during the stage of drug development. The metabolite profile investigation is important as the metabolites generated could be beneficial for therapy or leading to serious toxicity. This systematic review aims to summarize the research articles relating to the metabolite profile investigation of conventional drugs and herb-derived compounds for cancer chemotherapy, to examine factors influencing metabolite profiling of these drugs/compounds, and to determine the relationship between therapeutic efficacy and toxicity of their metabolites. The literature search was performed through PubMed and ScienceDirect databases up to January 2019. Out of 830 published articles, 78 articles were included in the analysis based on pre-defined inclusion and exclusion criteria. Both phase I and II enzymes metabolize the anticancer agents/herb-derived compounds . The major phase I reactions include oxidation/hydroxylation and hydrolysis, while the major phase II reactions are glucuronidation, methylation, and sulfation. Four main factors were found to influence metabolite formation, including species, gender, and route and dose of drug administration. Some metabolites were identified as active or toxic metabolites. This information is critical for cancer chemotherapy and anticancer drug development.

摘要

药物代谢是最重要的药代动力学过程之一,在药物开发阶段发挥着重要作用。代谢物谱研究很重要,因为生成的代谢物可能对治疗有益或导致严重的毒性。本系统综述旨在总结与癌症化疗用常规药物和草药化合物的代谢物谱研究相关的研究文章,考察影响这些药物/化合物代谢物谱分析的因素,并确定其代谢物治疗效果与毒性之间的关系。文献检索通过 PubMed 和 ScienceDirect 数据库进行,截至 2019 年 1 月。在 830 篇已发表的文章中,根据预先确定的纳入和排除标准,有 78 篇文章被纳入分析。I 期和 II 期酶均代谢抗癌药物/草药化合物。主要的 I 期反应包括氧化/羟化和水解,而主要的 II 期反应是葡萄糖醛酸化、甲基化和硫酸化。发现有四个主要因素影响代谢物的形成,包括物种、性别以及药物给药途径和剂量。一些代谢物被鉴定为活性或毒性代谢物。这些信息对于癌症化疗和抗癌药物开发至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7270/7154001/9aebad41c41e/DDDT-14-1401-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7270/7154001/9aebad41c41e/DDDT-14-1401-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7270/7154001/9aebad41c41e/DDDT-14-1401-g0001.jpg

相似文献

1
Metabolite Profiling in Anticancer Drug Development: A Systematic Review.代谢组学在抗癌药物研发中的应用:系统评价。
Drug Des Devel Ther. 2020 Apr 9;14:1401-1444. doi: 10.2147/DDDT.S221518. eCollection 2020.
2
Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.纳米颗粒作为传统药物和草药衍生化合物的递药系统用于癌症治疗的药代动力学研究:系统评价。
Int J Nanomedicine. 2019 Jul 23;14:5659-5677. doi: 10.2147/IJN.S213229. eCollection 2019.
3
A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.具有抗癌特性植物的药物代谢研究的系统综述:应用的方法与局限性
Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):173-225. doi: 10.1007/s13318-019-00582-8.
4
Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics.运用代谢组学揭示传统草药的抗癌机制。
Molecules. 2021 Oct 29;26(21):6541. doi: 10.3390/molecules26216541.
5
Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.基于生理的药代动力学(PBPK)模型在肿瘤药物研发中的应用及其准确性:一项系统综述。
Eur J Clin Pharmacol. 2018 Nov;74(11):1365-1376. doi: 10.1007/s00228-018-2513-6. Epub 2018 Jul 5.
6
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.主动靶向纳米粒给药系统在化疗药物及中药/天然药物治疗癌症中的应用:系统评价。
Int J Nanomedicine. 2018 Jul 4;13:3921-3935. doi: 10.2147/IJN.S165210. eCollection 2018.
7
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
8
Plant Polyphenolic Compounds Potentiates Therapeutic Efficiency of Anticancer Chemotherapeutic Drugs: A Review.植物多酚化合物增强抗癌化疗药物的治疗效果:综述。
Endocr Metab Immune Disord Drug Targets. 2021;21(2):246-252. doi: 10.2174/1871530320666200807115647.
9
Adaptive control methods for the dose individualisation of anticancer agents.抗癌药物剂量个体化的自适应控制方法。
Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003.
10
Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man.抗癌药物在人体中的剂量依赖性代谢、治疗效果及毒性。
Drug Metab Rev. 1983;14(6):1145-63. doi: 10.3109/03602538308991425.

引用本文的文献

1
The Comparative Metabolism of a Novel Hepatocellular Carcinoma Therapeutic Agent, 2,3-Diamino--(4-(benzo[d]thiazol-2-yl)phenyl)propanamide, in Human and Animal Hepatocytes.新型肝细胞癌治疗药物2,3-二氨基-γ-(4-(苯并[d]噻唑-2-基)苯基)丙酰胺在人和动物肝细胞中的代谢比较
Metabolites. 2024 Aug 1;14(8):425. doi: 10.3390/metabo14080425.
2
sp. nov., isolated from coastal sediment in Samila Beach, Thailand: insights into secondary metabolite synthesis as anticancer potential.sp. nov.,从泰国萨米拉海滩的海岸沉积物中分离得到:对作为抗癌潜力的次生代谢物合成的见解。
Front Microbiol. 2023 Nov 20;14:1226945. doi: 10.3389/fmicb.2023.1226945. eCollection 2023.
3

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
The Metabolism of Separase Inhibitor Sepin-1 in Human, Mouse, and Rat Liver Microsomes.Separase抑制剂Sepin-1在人、小鼠和大鼠肝脏微粒体中的代谢
Front Pharmacol. 2018 May 7;9:313. doi: 10.3389/fphar.2018.00313. eCollection 2018.
3
Characterization of in vitro and in vivo metabolism of leelamine using liquid chromatography-tandem mass spectrometry.
Editorial: Chromatographic analytical methods for quantifying newly marketed targeted antitumor drugs.
社论:用于定量新上市靶向抗肿瘤药物的色谱分析方法
Front Pharmacol. 2023 Oct 31;14:1308336. doi: 10.3389/fphar.2023.1308336. eCollection 2023.
4
Effectiveness of Treatments That Alter Metabolomics in Cancer Patients-A Systematic Review.改变癌症患者代谢组学的治疗方法的有效性——一项系统综述
Cancers (Basel). 2023 Aug 28;15(17):4297. doi: 10.3390/cancers15174297.
5
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators.色醇衍生异吲哚啉酮p53激活剂的代谢导向优化
Pharmaceuticals (Basel). 2023 Jan 19;16(2):146. doi: 10.3390/ph16020146.
6
Anticancer Potentials of the Lignan Magnolin: A Systematic Review.《芝麻脂素的抗癌潜力:系统评价》
Molecules. 2023 Apr 23;28(9):3671. doi: 10.3390/molecules28093671.
7
Chemotherapeutic and Safety Profile of a Fraction from Stem Bark.茎皮提取物的化疗及安全性概况
J Oncol. 2021 Dec 7;2021:9031975. doi: 10.1155/2021/9031975. eCollection 2021.
使用液相色谱-串联质谱法对利拉明的体外和体内代谢进行表征。
Xenobiotica. 2019 May;49(5):577-583. doi: 10.1080/00498254.2018.1480816. Epub 2018 Jun 12.
4
Metabolic profiles of neratinib in rat by using ultra-high-performance liquid chromatography coupled with diode array detector and Q-Exactive Orbitrap tandem mass spectrometry.采用超高效液相色谱联用二极管阵列检测器和Q-Exactive Orbitrap串联质谱法测定大鼠体内奈拉替尼的代谢谱。
Biomed Chromatogr. 2018 May 3:e4272. doi: 10.1002/bmc.4272.
5
Identification of Novel Pathways of Osimertinib Disposition and Potential Implications for the Outcome of Lung Cancer Therapy.鉴定奥希替尼处置的新途径及其对肺癌治疗结果的潜在影响。
Clin Cancer Res. 2018 May 1;24(9):2138-2147. doi: 10.1158/1078-0432.CCR-17-3555. Epub 2018 Feb 6.
6
Research and Development of (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics.(茵陈蒿)DC.作为胆管癌化疗药物的有前景候选物的研究与开发。
Evid Based Complement Alternat Med. 2017;2017:5929234. doi: 10.1155/2017/5929234. Epub 2017 Nov 14.
7
Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms.苯丁酸盐作为辅助化疗的潜力:细胞和分子抗癌机制概述
Chem Res Toxicol. 2017 Oct 16;30(10):1767-1777. doi: 10.1021/acs.chemrestox.7b00149. Epub 2017 Oct 3.
8
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.还原代谢影响缺氧靶向的苯并三嗪二氧化物抗癌剂SN30000在小鼠体内的毒性和药代动力学。
Front Pharmacol. 2017 Aug 11;8:531. doi: 10.3389/fphar.2017.00531. eCollection 2017.
9
Metabolite identification of AZD8055 in Sprague-Dawley rats after a single oral administration using ultra-performance liquid chromatography and mass spectrometry.采用超高效液相色谱和质谱联用技术对SD大鼠单次口服给药后AZD8055的代谢产物进行鉴定。
J Pharm Biomed Anal. 2017 Oct 25;145:473-481. doi: 10.1016/j.jpba.2017.06.059. Epub 2017 Jul 8.
10
Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo.槲皮素在体外和体内的抗癌及诱导凋亡作用。
Oncol Rep. 2017 Aug;38(2):819-828. doi: 10.3892/or.2017.5766. Epub 2017 Jun 28.